[144] Procter & Gamble Company SEC Filing

Rhea-AI Filing Summary

Procter & Gamble Company (PG) filing a Form 144 notifies the proposed sale of 13,677 shares of common stock through Morgan Stanley Smith Barney LLC on the NYSE with an aggregate market value of $2,118,635.69. The shares were acquired on 08/18/2025 as a Performance Stock Program Award from The Procter & Gamble Company and payment/vesting is recorded on 08/18/2025. The approximate date of sale listed is 08/19/2025. The filer indicates there have been no sales in the past three months and attests to possessing no undisclosed material adverse information.

Positive

• Full transaction detail disclosed: number of shares (13,677), aggregate market value ($2,118,635.69), broker (Morgan Stanley Smith Barney LLC), and exchange (NYSE).
• Source of shares specified: acquired under a Performance Stock Program Award from The Procter & Gamble Company on 08/18/2025.
• No sales in past three months reported, clarifying recent insider activity.

Negative

• None.

Insights

Securities Analyst

TL;DR: Routine insider sale notice disclosing quantity, value, broker, and acquisition method.

This Form 144 documents a proposed sale by a person who received 13,677 shares via a Performance Stock Program Award and intends to sell through Morgan Stanley Smith Barney. The filing provides clear transactional detail: acquisition date, nature of award, broker, aggregate market value, and planned sale date. No prior sales in the past three months are reported, which clarifies recent insider activity. This is a standard compliance disclosure rather than a corporate-level event.

Corporate Governance Expert

TL;DR: Filing meets insider sale disclosure requirements and includes the statutory attestation.

The notice includes required representations, including the signers assertion of no undisclosed material adverse information and a reminder about Rule 10b5-1 trading plans. It records the broker, planned sale date, and confirms the securities were acquired under a Performance Stock Program Award. The form appears complete for Rule 144 reporting purposes and contains the standard legal caution regarding intentional misstatements.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 38th Floor New York NY 10004	13677	2118635.69	2342371488	08/19/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	08/18/2025	Performance Stock Program Award	The Procter & Gamble Company			27734	08/18/2025	NA

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What is the proposed sale disclosed in PG's Form 144?

The filing proposes the sale of 13,677 shares of Procter & Gamble common stock with an aggregate market value of $2,118,635.69.

Who is the broker handling the proposed sale in PG's Form 144?

The broker named is Morgan Stanley Smith Barney LLC, 1 New York Plaza, 38th Floor, New York, NY.

When were the shares acquired that are being offered for sale (PG)?

The shares were acquired on 08/18/2025 as part of a Performance Stock Program Award from The Procter & Gamble Company.

What is the approximate date of sale listed in the filing for PG?

The filing lists the approximate date of sale as 08/19/2025.

Does the Form 144 report any securities sold in the past three months for PG?

The form states "Nothing to Report" for securities sold during the past three months.